Cryptococcus gattii in the United States: Genotypic Diversity of Human and Veterinary Isolates

Cryptococcus gattii: An Emerging Fungal Pathogen in the Southeastern United States

(2012) Brenda Sellers et al.   AMERICAN JOURNAL OF THE MEDICAL SCIENCES

Cryptococcus neoformans-Cryptococcus gattii Species Complex: an International Study of Wild-Type Susceptibility Endpoint Distributions and Epidemiological Cutoff Values for Fluconazole, Itraconazole, Posaconazole, and Voriconazole

(2012) A. Espinel-Ingroff et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical Manifestations of Cryptococcus gattii Infection: Determinants of Neurological Sequelae and Death

(2012) Sharon C-A. Chen et al.   CLINICAL INFECTIOUS DISEASES

Epidemiologic cutoff values for triazole drugs in Cryptococcus gattii: correlation of molecular type and in vitro susceptibility

(2012) Shawn R. Lockhart et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Cryptococcus gattii in the United States: Clinical Aspects of Infection With an Emerging Pathogen

(2011) J. R. Harris et al.   CLINICAL INFECTIOUS DISEASES

In vitro antifungal susceptibility profiles and genotypes of 308 clinical and environmental isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii serotype B from north-western India

(2011) A. Chowdhary et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Cryptococcus gattii Genotype VGI Infection in New England

(2011) Russell J. McCulloh et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Clonality and α-a Recombination in the Australian Cryptococcus gattii VGII Population - An Emerging Outbreak in Australia

(2011) Fabian Carriconde et al.   PLoS One

Fatal Disseminated Cryptococcus gattii Infection in New Mexico

(2011) Carla J. Walraven et al.   PLoS One

A Diverse Population of Cryptococcus gattii Molecular Type VGIII in Southern Californian HIV/AIDS Patients

(2011) Edmond J. Byrnes et al.   PLoS Pathogens

In Vitro Antifungal Susceptibilities and Amplified Fragment Length Polymorphism Genotyping of a Worldwide Collection of 350 Clinical, Veterinary, and Environmental Cryptococcus gattii Isolates

(2010) F. Hagen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In-hospital mortality of HIV-infected cryptococcal meningitis patients withC. gattiiandC. neoformansinfection in Gaborone, Botswana

(2010) Katherine T. Steele et al.   MEDICAL MYCOLOGY

Emergence and Pathogenicity of Highly Virulent Cryptococcus gattii Genotypes in the Northwest United States

(2010) Edmond J. Byrnes et al.   PLoS Pathogens

Correlation of Genotype and In Vitro Susceptibilities of Cryptococcus gattii Strains from the Pacific Northwest of the United States

(2009) N. Iqbal et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Molecular Evidence That the Range of the Vancouver Island Outbreak ofCryptococcus gattiiInfection Has Expanded into the Pacific Northwest in the United States

(2009) Edmond J. Byrnes III et al.   JOURNAL OF INFECTIOUS DISEASES

First Reported Case of Cryptococcus gattii in the Southeastern USA: Implications for Travel-Associated Acquisition of an Emerging Pathogen

(2009) Edmond J. Byrnes et al.   PLoS One

Genetic Diversity of the Cryptococcus Species Complex Suggests that Cryptococcus gattii Deserves to Have Varieties

(2009) Popchai Ngamskulrungroj et al.   PLoS One

Genotype and mating type analysis ofCryptococcus neoformansandCryptococcus gattiiisolates from China that mainly originated from non-HIV-infected patients

(2008) Xiaobo Feng et al.   FEMS YEAST RESEARCH

Association between fertility and molecular sub-type of global isolates ofCryptococcus gattiimolecular type VGII

(2008) Popchai Ngamskulrungroj et al.   MEDICAL MYCOLOGY

Six monophyletic lineages identified within Cryptococcus neoformans and Cryptococcus gattii by multi-locus sequence typing

(2007) M. Bovers et al.   FUNGAL GENETICS AND BIOLOGY